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Introduction
Previous studies have shown that primordial follicle depletion is the fundamental reason for physiological and pathological ovarian aging in mammalian females [1] . Historically, it was believed that the majority of the primordial follicle pool remains in a dormant state and declines with age under physiological conditions [2] . At approximately age 50, female fertility begins to decline along with the continued depletion of the primordial follicle pool until the occurrence of menopause [3] . However, certain pathological conditions, such as endometriosis, myomas, and chemotherapy drugs, are thought to cause premature ovarian failure [4] [5] [6] .
In recent years, this cornerstone understanding of a constant primordial follicle pool was challenged by the work of Johnson et al. [7] , who isolated mitotically active germ cells from juvenile and adult mouse ovaries. Based on the rates of oocyte atresia and clearance, these germ cells are needed to continuously replenish the follicle pool. Currently, several research groups have demonstrated the isolation of germline stem cells from the ovarian surface epithelium (OSE) of adult and even menopausal mouse and human ovaries [8] [9] [10] and have also successfully isolated and characterized long-term cultured ovarian germline stem cells (OGSCs) from neonatal and adult mouse ovaries [11] [12] [13] [14] [15] [16] [17] . However, the OSE layer has also been confirmed to be a normal, naturally present source of oocytes by producing stem cells in the embryonic or fetal period of life, and it is commonly referred to as the ''germinal'' epithelium [18] . Therefore, some of these recently published studies have shown that OGSCs might be present in the OSE layer.
The Hippo signaling pathway is a recently discovered novel signaling pathway [19] . In mammals, the core of the Hippo pathway comprises two upstream kinases (mammalian Sterile 20-like protein kinase I, MST1 and MST2, for short) and Salvador I (also known as SAV1 or WW45), as well as large tumor suppressor homolog 1 and 2 (LATS1 and LATS2), and YAP1 (Yes-associated protein) [20, 21] . Moreover, the Hippo signaling pathway has an essential function in the regulation of cancer stem cell proliferation, differentiation, migration and maturation, as well as the establishment of normal oocyte polarity and egg chamber structure [22] [23] [24] [25] . In ovarian CSCs, YAP promotes ovarian CSC tumorigenesis and regulates CSC self-renewal and differentiation [26, 27] . The transcriptional co-activator with PDZbinding motif (TAZ) is a transcriptional effector of the Hippo signaling cascade and regulates cell proliferation and tumorigenesis [21, 28, 29] . In addition, previous studies have shown that YAP acts as an oncogene in a subtype of breast CSCs and lung CSCs, thus serving as a good target for molecular therapies against cancers. The mammalian kinases Mst1 and Mst2 are most abundant in some kinds of tumor tissue systems. MST1 overexpression not only decreases cell proliferation but also induces apoptosis of the human breast cancer cell line MCF-7. Moreover, the overexpression of MST1 can inhibit cell proliferation and promote the cytoplasmic localization and phosphorylation of YAP (Ser127) protein, which may be one of the tumor inhibitory mechanisms of the MST1 gene [30, 31] . Consistent with the major roles of MST in cell proliferation and apoptosis, LATS regulates the balance between proliferation and differentiation during adipose development. In addition, LATS knockout leads to the improved efficiency of pluripotent stem cells (IPS), suggesting a barrier to reprogramming and oncogenic transformation [32] [33] [34] .
The OSE layer involves cell-cell contact and local signaling, which may play very important roles in OGSC growth and development [35] . Previous studies have shown that the Hippo signaling pathway forms a cross network with a variety of factors and multiple signaling pathways such as Notch, TGFβ, c-myc, and PI3K/AKt, which are crucial for the self-renewal and differentiation of stem cells [22, [36] [37] [38] [39] . Importantly, several lines of our evidence suggest that the upstream activation of Notch signaling pathways, which have been proven to play a role in germ-line stem cells in ovaries [40, 41] , and the Hippo signaling pathway have a spatio-temporal correlation with the size of the primordial follicle pool [42] . Hence, the aim of this study is to reflect the variation in the number of OGSCs and explore 
Materials and Methods
Animals 7days, 2 month, 10 months and 20months old KM female mice were housed at the Center of Experimental Animals, Nan Chang University, on a 12-h light: dark cycle and were given access to food (Keao-Xieli, Beijing, China) and water ad libitum. Ovarian failure was induced in one group of 6-weekold KM mice by intraperitoneal injection of cyclophosphamide (120 mg/kg) and busulfan (12 mg/kg) simultaneously. However, ovarian failure was induced by the other group by infusing the stomachs of the mice with Tripterygium wilfordii polycoride tablets. According to the previous reported, we used lavage needle, gently gavaged needle from the mouth of mice, arrived the esophagus and pushed TPT liquid (0.6 mg/ (100g/d) for 9d). The controls were intraperitoneally injected with saline or had it infused into the stomach. All procedures (including the use of animals in this study) were reviewed and approved by the ethical committee of Nan Chang University.
Histological analysis of ovarian tissue
For the evaluation of follicles, ovaries were fixed in 4% paraformaldehyde and prepared as paraffin blocks; 5-mm sections were obtained serially and stained with hematoxylin-eosin (HE). Immunostaining of ovaries from 7 days, 2 month and 20 months old mice were performed according to previously published procedures [8] . The primary antibodies used in this study were as follows: anti-MVH (1:100, ab27591), anti-OCT4 (1:100, ab18976), anti-YAP1 (1:100, ab56701), anti-LATS2 (1:100, ab54073), and anti-MST1 (1:100, ab51134). The secondary antibodies used in this study were goat anti-mouse and goat anti-rabbit IgG conjugated with fluorescein isothiocyanate at dilution of 1:200 (proteintech, China). Then, the tissues were stained with DAPI, and all of the images were taken using a NIKON Eclipse 80i microscope.
Quantitative real-time PCR
The total RNA of different stages of mice and treated ovarian surface epithelium was extracted with TRIzol reagent (TaKaRa). cDNA was synthesized using a PrimeScript RT reagent Kit with gDNA Eraser (TaKaRa). Quantitative RT-PCR was performed using an ABI7000 PCR instrument (Applied Biosystems, Foster City, CA, USA) using two-stage program parameters provided by the manufacturer. The primers used for PCR are listed in Table 1 . Every sample was amplified in triplicate to normalize system and pipetting errors, and GAPDH was used as the reference gene to normalize the expression results.
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Western blot analysis Total protein was extracted from different ovarian tissue with RIPA lysis solution (Beyotime, P0013C). The proteins were subjected to SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) and then transferred to PVDF membranes (Millipore Corp., Bedford, MA) and processed per the antibody manufacturer's instructions. The antibodies used for western blotting were anti-YAP1 (1:100, ab56701, Abcam), anti-S127 phosphorylated-YAP1 (1:10000, ab76252, Abcam), anti-MST1 (1:10000, ab51134, Abcam), anti-LATS2 (1:100, ab54073, Abcam), anti-MVH (1:5000, ab27591, Abcam), anti-OCT4 (1:100, ab18976, Abcam) and anti-GAPDH (1:1000, ab1801, Abcam). The results were analyzed by gel imaging and analysis system and converted to a semi-quantitative data by Gelscan software. The level of GAPDH was quantified at the same time as an internal quantitative control. Each experiment was repeated at least three times.
Statistical methods
All analyses were performed using GraphPad Prism 5.0 (GraphPad Software, Inc., San Diego, CA). The statistical comparisons among different groups were analyzed by Student's paired t-test. The threshold of p < 0.05 was considered significant; p < 0.01 and p < 0.001 were each considered extremely significant.
Results

Expression of OGSC specific genes during physiological ovarian aging in mice
To confirm follicle depletion in the 7D, 2M and 20M mice, we performed histological analysis of the ovaries. As seen in Fig. 1A , as the age of the mice increased, the number of primordial and mature follicles was reduced, while the number of atretic follicles increased gradually (p < 0.05, p < 0.01, and p < 0.001). Meanwhile, the corpus luteum level was highest in 2M mice (p < 0.001). The mature follicles had most the significant difference in 2M and 20M mice (p < 0.001).
Western blotting and RT-PCR assays were used to detect MVH/OCT4 expression in the ovarian cortexes of 7D, 2M and 20M mice. The western blot results showed that the protein expression of MVH/OCT4 was decreased significantly as mice aged (p < 0.001) (Fig. 1B) , and the relative mRNA expression of MVH/OCT4 showed a significant decrease among 2M, 10M and 20M mice compared with the 7D mice (p < 0.01, p < 0.001). MVH expression decreased significantly (p < 0.05, p < 0.01) among the 10M and 20M mice compared with the 2M mice, but OCT4 expression was significantly reduced when comparing the 2M and 20M mice (p < 0.05) (Fig. 1C) . Subsequently, we obtained micrographs of mouse ovarian cortexes in 7D, 2M and 20M mice to determine the MVH/OCT4 gene expression. As shown in Fig.1D , MVH/ OCT4 expression was highest in ovarian cortexes from 7D mice, which then significantly down-regulated from 2M to 20M, with almost no expression at 20M. These data suggest that ovarian stem cells are present in the ovarian cortex at different stages and that their levels gradually decrease with age in mice.
Expression of OGSC specific genes during pathological ovarian aging in mice
In the TPT and CY/BUS mouse models, we also showed that the numbers of primordial follicles, mature follicles and corpus luteum were decreased significantly (p < 0.001). The number of atretic follicles increased gradually compared with the control group (p < 0.001), but there was no significant difference between the control and CY/BUS-treated mice (p < 0.05) ( Fig. 2A) . However, we found that the numbers of primordial follicles, mature follicles, atretic follicles and corpus luteum in the CY/BUS group were significantly decreased compared with those of the TPT group (p < 0.05, p < 0.01, p < 0.001). HE-stained sections of ovaries revealed fewer or almost no viable follicles in chemotherapy-treated ovaries.
We established western blot and RT-PCR methods to assess whether MVH/OCT4 expression varies in TPT-and CY/BUS-treated mouse ovarian cortexes. Western blot analysis of MVH/OCT4 revealed that the expression levels were significantly lower compared with the control group (p < 0.01, p < 0.001) but were not significantly different between the
ovarian cortexes of TPT-and CY/BUS-treated mice (p>0.05) (Fig. 2B) . The relative mRNA expression of MVH/OCT4 showed a significant decrease compared with the control group (p < 0.05, p < 0.01) (Fig. 2C) . Meanwhile, the MVH levels were significantly different in the TPT and CY/BUS groups relative to the control (p < 0.05). In addition, double immunofluorescent staining showed the expression of MVH/OCT4 proteins in the ovarian cortexes of control and TPT-and CY/BUS-treated mice. A lower level of MVH was associated with a significant down-regulation in the pathological aging of the ovarian cortex of mice compared with the control. Similar to MVH, the expression of OCT4 was also lower in TPT-and CY/BUS-treated mice than in control mice (Fig. 2D) . These data also suggest that OSEs are present in the mouse ovarian cortex during pathological ovarian aging and their levels are decreased in TPT-and CY/BUS-treated mice. (Fig. 3A) . In addition, the protein expression of pYAP1 was the highest in the ovarian cortex of 7D mice and lowest in 20M mice (Fig. 3A) (p < 0.05, p < 0.01). As the age of the mice increased, the value of pYAP1/YAP1 decreased in 20M mice compared to 7D mice ( Fig. 3B) (p < 0.05, p < 0.01). These results indicate that the effectors of the Hippo pathway and pYAP1 are correlated with the proliferative ability of OGSCs. As shown in Fig. 3D , MST1, LATS2 and YAP1 were distinctly localized in the mouse ovarian cortexes. The magnitude of incorporated LATS2 or MST1 in the ovarian cortexes of 2M and 20M mice was visibly lower than that observed in 7D mice. Conversely, YAP1 accumulation was greater in the ovarian cortexes of 2M mice compared to 7D mice, and YAP1 was not observed in 20M mice.
Expression of Hippo signaling components in ovarian cortex during pathological ovarian aging
Given the above results, we next assessed the expression of Hippo signaling pathway members during pathological aging in the mouse ovarian cortex caused by TPT and CY/ Fig.4 , the mRNA and protein expression levels of YAP1 were significantly decreased between the control and CY/BUS-treated groups (p < 0.05, p < 0.01, p < 0.001), whereas the expression of YAP1 did not differ significantly between the control and TPTtreated groups. LATS2 mRNA and protein up-regulation persisted when mice were treated with TPT or CY/BUS (p < 0.05, p < 0.01). However, MST1 expression was different from the level of LATS2 expression in that the relative mRNA expression of MST1 was lower in the TPT-or CY/BUS-treated mice compared with the control group (p < 0.05). In addition, the total protein level of MST1 was decreased (p < 0.01), and there was no difference in the (Fig. 4A, 4C ). Similar to YAP1, pYAP1 protein also decreased in the TPT-or CY/BUStreated group (Fig. 4B) (p < 0.01), and pYAP1 did not differ significantly between the control and TPT-treated group. In addition, the value of pYAP1/YAP1 increased between the control and CY/BUS-treated group(p < 0.05, p < 0.01) and was significantly different between the TPT and CY/BUS groups (p < 0.05). Subsequently, the micrographs showed that MVH was also expressed in the mouse ovarian cortex and was down-regulated in the TPT and CY/BUS groups compared with control group. Like the IF results in the mouse ovarian cortex during physiological ovarian aging, the Hippo genes were also present in the mouse ovarian cortex during pathological ovarian aging. Specifically, the most intense staining was that of LATS2 in TPT-treated mice than CY/BUS and control groups. Moreover, the intensity of YAP1 and MST1 staining in TPTor CY/BUS-treated mice was distinctly lower than control (Fig. 4D) .
Discussion
Morphometric analysis of the ovaries showed that the number of primordial follicles make up most of the total follicles in 7D mice ovaries. With further growth and differentiation, primordial follicles are gradually replaced by different levels of follicles (Fig.  1A) . Meanwhile, there were no normal follicles except atretic follicles in TPT-and CY/BUStreated ovaries, unlike the control (Fig. 2A) . Therefore, we chose these physiological and pathological ovarian aging models as experimental groups to reflect the variation in Hippo signaling pathway components during the development of OGSCs over the reproductive life of female mice.
To identify and confirm the presence of OGSCs in different stages of mouse ovaries, we located ovarian cells positive for mouse vasa homologue (MVH) and OCT4 protein, which are expressed exclusively in germ cells and pluripotent stem cells, respectively [43, 44] . The immunocytochemical results confirmed that MVH and OCT4 were concurrently co-expressed in different stages of mouse ovarian cortex (Fig. 1D) . Moreover, we have provided evidence for the expression of MVH/OCT4 genes and proteins in the different stages of mouse ovaries (Fig1 A, B, C) . MVH and OCT4 were maximally expressed in 7D mice ovaries compared with the other groups, but were also expressed in 2M mice, and minimally expressed at 10M. Up to 20M, there was almost no detectable MVH or OCT4 expression. Briefly, OGSCs were observed in the OSE layers, and the number of OGSCs gradually decreased from 7D to 20M. However, previous studies have shown that OGSCs can complement the consumption of primordial follicles via proliferation and differentiation [45] . However as aging progresses the number of OGSCs decreases, which may cause the depletion rate of the follicle pool to exceed the supplementation rate during the fertility exuberant female mice,. These changes may be the root cause of menopause symptoms around age 50.
Our recent results revealed that the Hippo signaling pathway is expressed in mouse ovaries and the expression of the core components of the Hippo pathway change during mouse follicular development [42] . In this study, as seen in Fig. 3 , MST1 and LATS2 were most highly expressed in the ovarian cortexes of 7D mice, but YAP1 was more abundant in 2M than in 7D mice and was absent in 20M mice. Whereas the primordial follicles start developing unceasingly with age, follicular growth is accompanied by oocyte maturation and granular cell proliferation. MST1 and LATS2 were down-regulated during follicle formation and depletion with age, but the expression level of YAP1 was up-regulated at all time points until 10M. Based on this result, we hypothesized that the 7D mice were not in the gonadotropin phase because they could not yet regulate the levels of stem cells and OGSC proliferation remained in the stationary phase of the cell cycle [46] . However, there is increased differentiation of follicles with advanced age when gonadotropin levels are elevated and the proliferation rate of OGSCs is accelerated. This state is maintained until the age of 10M. Therefore, it is believed that the phenomenon may be involved in the expression Fig. 3D , MST1, LATS2, YAP1 and MVH were specifically coexpressed in the mouse ovarian cortex, and the levels of MST1 and LATS2 also decrease among 7D, 2M and 20M mice, unlike the expression of YAP1. Moreover, the change in pYAP1 expression is similar to that of YAP1, but the ratio of pYAP1/YAP1 decreased significantly among 7D, 2M and 20M mice. High cell-density activates the Hippo pathway kinases and promotes the phosphorylation of YAP1 on serine 127, which leads to its nuclear export and growth inhibition [47, 48] . Furthermore, the results show that Hippo signaling genes are active in different stages of mouse ovarian cortex, and OGSCs had a positive correlation with the level of MST1 and LATS2 and were contrary to the changes in YAP1 expression. Likewise, MVH and OCT4 were co-expressed and these levels were remarkably decreased in the ovarian cortex of TPT-and CY/BUS-treated mice (Fig2). The expression patterns presented here are similar to that shown in a previous study, which showed that ovarian stem cells are present in the OSE during ovarian failure and patients with no naturally present follicles and oocytes [8, 10] . Previous studies have suggested that differences in follicle depletion are caused by two drugs: TPT and CY/BUS [49, 50] . However, there is little information on the expression of MVH and OCT4 in the ovaries of TPT-and CY/BUS-treated mouse models. In our study, we demonstrated that MVH and OCT4 are present in the TPTand CY/BUS-treated mouse ovarian cortexes, and the changes of OGSCs in TPT-and CY/BUStreated mice are consistent with the results seen for physiological ovarian aging in mice. Figs. 2B, C suggest that there is almost no difference in the effect of these two on the presence and quantity of OGSCs. In addition, the expression of OCT4 in the mouse ovarian cortex of both the TPT-and CY/BUS-treated mice was higher than that in 20M mice, suggesting that there are some putative stem cells in the ovarian cortex of mice undergoing pathological ovarian aging. Given these results, it has been speculated that OGSC proliferation suppression may be the key cause of follicular depletion by TPT and CY/BUS treatment and may also be the core cause of pathological ovarian aging caused by chemical treatment in cancer patients.
We assessed the chemotherapy-induced ovarian follicular loss in mice, arguing that Hippo signaling factors are important for the development of OGSCs. However, the mechanisms involved in the changes of Hippo signaling genes during chemotherapy-induced ovarian follicular loss in mice remain obscure. MST1, LATS2 and YAP1 were significantly detected in the ovarian cortex of the TPT-and CY/BUS-treated mice and the control group, respectively. The results of Fig. 4A , B indicate that the expression of MST1 and YAP1 were decreased after TPT and CY/BUS treatment, whereas the mRNA and protein levels of LATS2 were significantly higher in the TPT-and CY/BUS-treated group compared to the control. The amount of MST1, LATS2 and YAP1 protein expression was significantly different within the TPT-and CY/BUS-treated mice ovaries, but the amount of mRNA expression for MST1, LATS2 and YAP1 are not significantly different from the control levels. However, we can hypothesize about the role of Hippo signaling in pathological ovarian aging as follows: First, RNA is converted into protein by a complex regulatory process [51, 52] . These genes in the TPT-and CY/BUS-treated mouse ovaries are disturbed by these drugs, leading to a suspension of translation and resulting in a significant decrease in the protein levels of Hippo signaling components. Second, post-translational processing takes place [53] . If protein processing after translation is not correct, the protein may be degraded by endopeptidase, and activity may also be changed or lead to the loss of required core components for translation into protein in the TPT-and CY/BUS-treated mouse ovaries. This problem will finally cause the change in protein levels. It is known that MST and LATS are suppressor genes in the Hippo signaling pathway [25, 28, 54] . Interestingly, MST1 mRNA and protein levels are not consistent with the expression of LATS in the TPT-and CY/BUS -treated mouse ovaries. Based on all of these previous studies, it seems that different protein kinases are involved in activating MST and LATS [55] , resulting in the observation of an inverse trend in MST1 protein expression compared to the level of LATS2. In addition, the proteins of pYAP1 were decreased in the TPT-and CY/BUS -treated group, as shown using western blotting, and the ratio of pYAP1/YAP 1increased significantly. 
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In conclusion, this study demonstrated that Hippo signaling genes are expressed in OGSCs, and the number of OGSCs correlates with the dynamic changes of Hippo signaling. These findings confirmed that the Hippo signaling pathway may be involved in dictating the development schedule of OGSCs. In a follow-up study, we plan to use OGSC line as a useful tool to study Hippo signaling molecules and the effect on OGSCs transfected by lentivirus to mice ovaries. These future studies could be used for further research aimed at the autologous treatment of ovarian infertility and degenerative diseases.
